Wednesday, October 15, 2025, 8:00 AM Pacific Daylight Time
Cell and Gene Therapy continues to transform the world of medicine, by blending aseptic manufacturing and biotechnology to create small-batch, temperature-sensitive treatments that hold life-changing potential. Ensuring product quality and regulatory compliance requires resilient monitoring of environmental conditions throughout the manufacturing process.
This webinar, led by Vaisala Senior GxP Regulatory Expert Paul Daniel, will explore the unique monitoring challenges faced in Cell and Gene Therapy and discuss adaptable strategies for maintaining compliance and quality. Attendees will gain practical insights into how robust monitoring practices can help bridge the gap between regulatory requirements and operational performance, reducing the risk of non-compliance.
The session will also address how scalable monitoring approaches can support the fast-paced, small-scale production typical of this sector. Join us to learn how forward-thinking monitoring solutions can help meet the evolving needs of Cell and Gene Therapy manufacturing and ensure the safe delivery of these advanced therapies.
Who should attend:
Offered Free by: Vaisala
See All Resources from: Vaisala
Thank you
This download should complete shortly. If the resource doesn't automatically download, please, click here.